Inhibition of nuclear factor-κB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy
- 1 January 2003
- journal article
- Published by Elsevier in Kidney International
- Vol. 63 (1) , 306-314
- https://doi.org/10.1046/j.1523-1755.2003.00714.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Transcription factor-κB (NF-κB) and renal diseaseKidney International, 2001
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-κB activation in rat hepatocytesJournal of Hepatology, 1999
- Interleukin 1β-Induced Expression of Nitric Oxide Synthase in Rat Renal Mesangial Cells Is Suppressed by Cyclosporin ABiochemical and Biophysical Research Communications, 1995
- FUNCTIONAL AND STRUCTURAL CHARACTERISTICS OF EXPERIMENTAL FK 506 NEPHROTOXICITYClinical and Experimental Pharmacology and Physiology, 1995
- Lipid peroxidation accompanies cyclosporine nephrotoxicity: Effects of vitamin EKidney International, 1995
- CYCLOSPORINE NEPHROTOXICITY: ATTENUATION BY AN ANTIOXIDANT-INHIBITOR OF LIPID PEROXIDATION IN VITRO AND IN VIVOTransplantation, 1994
- Fibrogenic cytokines: the role of immune mediators in the development of scar tissueImmunology Today, 1991
- Molecular cloning of rat monocyte chemoattractant protein-1 (MCP-1) and its expression in rat spleen cells and tumor cell linesBiochemical and Biophysical Research Communications, 1991
- Optimal dithiocarbamate structure for immunomodulator actionPublished by Elsevier ,1988